Dobrin, Anton
$105,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2017-2018
États-Unis
Evaluation of novel cancer immunotherapies that combine the potency of chimeric antigen receptors and the intracellular targeting of T-cell receptors